hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis

被引:29
|
作者
Han, Fengjiao [1 ]
Zhong, Chaoqin [1 ,2 ]
Li, Wei [1 ]
Wang, Ruiqing [1 ]
Zhang, Chen [1 ]
Yang, Xinyu [1 ]
Ji, Chunyan [1 ]
Ma, Daoxin [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250012, Peoples R China
[2] Yantai Mt Hosp, Dept Hematol, Yantai 264000, Peoples R China
基金
中国国家自然科学基金;
关键词
AML; biomarker; circRNAs; CREBRF; hsa_circ_0001947; hsa-miR-329-5p; therapy; CIRCULAR RNAS; GASTRIC-CANCER; CELL-GROWTH; IDENTIFICATION; CREBRF; SPONGE; GENE; ACTS;
D O I
10.2217/epi-2019-0352
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: Accumulating evidence has indicated that circular RNAs (circRNAs) are involved in cancer biology. However, their roles in acute myeloid leukemia (AML) remain unclear. Therefore, we aimed to define novel circRNAs involved the development and progression of AML. Materials & methods: We used circRNAs microarray to determine the differential expression profile. Quantitative reverse transcription PCR analyzed the expression of hsa_circ_0001947. The siRNA assesses the function of hsa_circ_0001947in vitro and in vivo. A dual-luciferase and mimics/inhibitor were to determine the target gene relationship. Results:hsa_circ_0001947 functions as a tumor inhibitor to suppress AML cell proliferation through hsa-miR-329-5p/CREBRF axis. Conclusion:hsa_circ_0001947 may be as a novel potential biomarker for the treatment of AML.
引用
下载
收藏
页码:935 / 953
页数:19
相关论文
共 50 条
  • [41] Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis
    Zhi-Min Deng
    Fang-Fang Dai
    Quan Zhou
    Yan-Xiang Cheng
    BMC Cancer, 21
  • [42] Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis
    Deng, Zhi-Min
    Dai, Fang-Fang
    Zhou, Quan
    Cheng, Yan-Xiang
    BMC CANCER, 2021, 21 (01)
  • [43] hsa_circ_0000129 targets miR-383-5p/tropomyosin 3 axis to facilitate ovarian cancer progression
    Li, Yuan
    Liu, Can
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2024,
  • [44] Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma
    Chen, Yupeng
    Wu, Yuanyuan
    CANCER BIOMARKERS, 2023, 37 (01) : 53 - 66
  • [45] Hsa_circ_0119412 Contributes to Development of Retinoblastoma by Targeting miR-186-5p/ELK4 Axis
    Li, Xiaodong
    Wang, Ying
    Zhang, Baoying
    Mao, Rui
    Wang, Zhongkui
    Jiang, Tingyu
    Song, Haibin
    MOLECULAR BIOTECHNOLOGY, 2023, 65 (10) : 1608 - 1618
  • [46] CircularRNA Hsa_circ_0093335 promotes hepatocellular carcinoma progression via sponging miR-338-5p
    Qin, Xiangyu
    Zhou, Lingyu
    Shen, Yaojie
    Gu, Yuwei
    Tang, Jia
    Qian, Junwei
    Cui, An
    Chen, Mingquan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (24) : 4080 - 4092
  • [47] Hsa_circ_0119412 Contributes to Development of Retinoblastoma by Targeting miR-186-5p/ELK4 Axis
    Xiaodong Li
    Ying Wang
    Baoying Zhang
    Rui Mao
    Zhongkui Wang
    Tingyu Jiang
    Haibin Song
    Molecular Biotechnology, 2023, 65 : 1608 - 1618
  • [48] Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment
    Song, Jialin
    Liu, Qing
    Han, Lei
    Song, Tiantian
    Huang, Sihao
    Zhang, Xinyao
    He, Qiuming
    Liang, Chenxi
    Zhu, Shuai
    Xiong, Bin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [49] Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis
    Hong-Yu Shen
    Liu-Xi Shi
    Lin Wang
    Le-Ping Fang
    Wei Xu
    Ju-Qing Xu
    Bo-Qiang Fan
    Wei-Fei Fan
    Journal of Translational Medicine, 19
  • [50] Circular RNA hsa-circ-000881 suppresses the progression of lung adenocarcinoma in vitro via a miR-665/PRICKLE2 axis
    Huang, Chu
    Yue, Weiming
    Li, Lin
    Li, Shuhai
    Gao, Cun
    Si, Libo
    Qi, Lei
    Cheng, Chuanle
    Lu, Ming
    Chen, Guanqing
    Cui, Jingjing
    Zhao, Renchang
    Li, Yongmeng
    Tian, Hui
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)